Skip to main content
Clinical Trials/IRCT20130812014333N185
IRCT20130812014333N185
Recruiting
Phase 2

Comparative study of the effect of intravitreal injection of bevacizumab versus simultaneous intravitreal injection of bevacizumab and triamcinolone acetonide in patients with retinal venous occlusion

Kermanshah University of Medical Sciences0 sites58 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Retinal vascular occlusions.
Sponsor
Kermanshah University of Medical Sciences
Enrollment
58
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients who have had retinal vein occlusion in the last 12 weeks based on their history

Exclusion Criteria

  • History of any previous treatment, including macular laser or intravitreal injection
  • Having ocular hypertension
  • Vision better than 20/40 or central macular thickness less than 250 microns
  • Media opacity
  • Any type of neovascularization or with retinal arterial occlusion or symptoms in favor of treatment such as cilioretinal and retinal shunts
  • Any retinal disease

Outcomes

Primary Outcomes

Not specified

Similar Trials